Found: 90
Select item for more details and to access through your institution.
The STELLAR trial: a phase II/III randomized trial of high-dose, intermittent sunitinib in patients with recurrent glioblastoma.
- Published in:
- Brain Communications, 2024, v. 6, n. 4, p. 1, doi. 10.1093/braincomms/fcae241
- By:
- Publication type:
- Article
Circulating Tumour DNA as Biomarker for Colorectal Liver Metastases: A Systematic Review and Meta-Analysis.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 21, p. 2520, doi. 10.3390/cells12212520
- By:
- Publication type:
- Article
CD276-Positive Circulating Endothelial Cells Do Not Predict Response to Systemic Therapy in Advanced Colorectal Cancer.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 1, p. 1, doi. 10.3390/cells9010124
- By:
- Publication type:
- Article
Toward an improved conceptualization of emotions in patients with cancer.
- Published in:
- Frontiers in Psychiatry, 2024, p. 1, doi. 10.3389/fpsyt.2024.1352026
- By:
- Publication type:
- Article
Dendritic cell phenotype and function in a 3D co-culture model of patient-derived metastatic colorectal cancer organoids.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1105244
- By:
- Publication type:
- Article
Plasma Ghrelin Levels Are Associated with Anorexia but Not Cachexia in Patients with NSCLC.
- Published in:
- Frontiers in Physiology, 2017, v. 8, p. 1, doi. 10.3389/fphys.2017.00119
- By:
- Publication type:
- Article
Combination of a six microRNA expression profile with four clinicopathological factors for response prediction of systemic treatment in patients with advanced colorectal cancer.
- Published in:
- PLoS ONE, 2018, v. 13, n. 8, p. 1, doi. 10.1371/journal.pone.0201809
- By:
- Publication type:
- Article
Genomic landscape of metastatic colorectal cancer.
- Published in:
- Nature Communications, 2014, v. 5, n. 11, p. 5457, doi. 10.1038/ncomms6457
- By:
- Publication type:
- Article
Alternative scheduling of pulsatile, high dose sunitinib efficiently suppresses tumor growth.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2016, v. 35, p. 1, doi. 10.1186/s13046-016-0411-2
- By:
- Publication type:
- Article
Candidate biomarkers for treatment benefit from sunitinib in patients with advanced renal cell carcinoma using mass spectrometry-based (phospho)proteomics.
- Published in:
- Clinical Proteomics, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12014-023-09437-6
- By:
- Publication type:
- Article
Time dependent effect of cold ischemia on the phosphoproteome and protein kinase activity in fresh-frozen colorectal cancer tissue obtained from patients.
- Published in:
- Clinical Proteomics, 2021, v. 18, n. 1, p. 1, doi. 10.1186/s12014-020-09306-6
- By:
- Publication type:
- Article
Effects of Cancer Presence and Therapy on the Platelet Proteome.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 15, p. 8236, doi. 10.3390/ijms22158236
- By:
- Publication type:
- Article
ShrinkBayes: a versatile R-package for analysis of count-based sequencing data in complex study designs.
- Published in:
- BMC Bioinformatics, 2014, v. 15, n. 1, p. 1, doi. 10.1186/1471-2105-15-116
- By:
- Publication type:
- Article
Phosphotyrosine-Based Phosphoproteomics of a Panel AML Cell Lines Reveals Oncogenic Signaling and Hyperactive Tyrosine Kinases as Targets for Treatment.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S2, doi. 10.1016/j.clml.2017.09.026
- By:
- Publication type:
- Article
Patient-Reported Symptom Monitoring During Chemotherapy.
- Published in:
- 2017
- By:
- Publication type:
- letter
Locoregionally Recurrent Colon Cancer: How Far Have We Come? A Population-Based, Retrospective Cohort Study.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 3, p. 1726, doi. 10.1245/s10434-022-12689-5
- By:
- Publication type:
- Article
ASO Visual Abstract: In Patients Undergoing CRS/HIPEC for Colorectal Adenocarcinoma with Peritoneal Metastases, Presence of Ascites on Computed Tomography Imaging is Not a Prognostic Marker for Survival.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
In Patients Undergoing CRS/HIPEC for Colorectal Adenocarcinoma with Peritoneal Metastases, Presence of Ascites on Computed Tomography Imaging is not a Prognostic Marker for Survival.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 8, p. 5256, doi. 10.1245/s10434-022-11718-7
- By:
- Publication type:
- Article
Pharmacokinetic Effects and Safety of Olaparib Administered with Endocrine Therapy: A Phase I Study in Patients with Advanced Solid Tumours.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Accuracy of the Delirium Observational Screening Scale (DOS) as a screening tool for delirium in patients with advanced cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Predictors for use of psychosocial services in patients with metastatic colorectal cancer receiving first line systemic treatment.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Feasibility, validity and reliability of objective smartphone measurements of physical activity and fitness in patients with cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Interferon- and STING-independent induction of type I interferon stimulated genes during fractionated irradiation.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-01962-2
- By:
- Publication type:
- Article
Development of a miRNA-based classifier for detection of colorectal cancer molecular subtypes.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 14, p. 2693, doi. 10.1002/1878-0261.13210
- By:
- Publication type:
- Article
Molecular profiles of response to neoadjuvant chemoradiotherapy in oesophageal cancers to develop personalized treatment strategies.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 4, p. 901, doi. 10.1002/1878-0261.12907
- By:
- Publication type:
- Article
RAS and BRAF mutations in cell‐free DNA are predictive for outcome of cetuximab monotherapy in patients with tissue‐tested RAS wild‐type advanced colorectal cancer.
- Published in:
- Molecular Oncology, 2019, v. 13, n. 11, p. 2361, doi. 10.1002/1878-0261.12550
- By:
- Publication type:
- Article
<sup>11</sup>C-sorafenib and <sup>15</sup>O-H<sub>2</sub>O PET for early evaluation of sorafenib therapy.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.251611
- By:
- Publication type:
- Article
<sup>11</sup>C-sorafenib and <sup>15</sup>O-H<sub>2</sub>O PET for early evaluation of sorafenib therapy.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.251611
- By:
- Publication type:
- Article
Androgen and Estrogen Receptor Imaging in Metastatic Breast Cancer Patients as a Surrogate for Tissue Biopsies.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 12, p. 1906, doi. 10.2967/jnumed.117.193649
- By:
- Publication type:
- Article
PET/CT-Derived Whole-Body and Bone Marrow Dosimetry of <sup>89</sup>Zr-Cetuximab.
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 2, p. 249, doi. 10.2967/jnumed.114.147819
- By:
- Publication type:
- Article
Efficacy and Safety of Panitumumab in Patients With RAF/RAS-Wild-Type Glioblastoma: Results From the Drug Rediscovery Protocol.
- Published in:
- Oncologist, 2024, v. 29, n. 5, p. 431, doi. 10.1093/oncolo/oyad320
- By:
- Publication type:
- Article
Higher Muscle Strength Is Associated with Prolonged Survival in Older Patients with Advanced Cancer.
- Published in:
- Oncologist, 2018, v. 23, n. 5, p. 580, doi. 10.1634/theoncologist.2017-0193
- By:
- Publication type:
- Article
Losses of Chromosome 5q and 14q Are Associated with Favorable Clinical Outcome of Patients with Gastric Cancer.
- Published in:
- Oncologist, 2012, v. 17, n. 5, p. 653, doi. 10.1634/theoncologist.2010-0379
- By:
- Publication type:
- Article
Analysis of AKT and ERK1/2 protein kinases in extracellular vesicles isolated from blood of patients with cancer.
- Published in:
- Journal of Extracellular Vesicles, 2014, v. 3, p. 1, doi. 10.3402/jev.v3.25657
- By:
- Publication type:
- Article
A specific microRNA profile as predictive biomarker for systemic treatment in patients with metastatic colorectal cancer.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 20, p. 7558, doi. 10.1002/cam4.3371
- By:
- Publication type:
- Article
Identification of patients with cancer with a high risk to develop delirium.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 8, p. 1861, doi. 10.1002/cam4.1106
- By:
- Publication type:
- Article
Optimal treatment scheduling of ionizing radiation and sunitinib improves the antitumor activity and allows dose reduction.
- Published in:
- Cancer Medicine, 2015, v. 4, n. 7, p. 1003, doi. 10.1002/cam4.441
- By:
- Publication type:
- Article
Combination of variations in inflammation- and endoplasmic reticulum-associated genes as putative biomarker for bevacizumab response in KRAS wild-type colorectal cancer.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-65869-2
- By:
- Publication type:
- Article
Diagnostic Performance of [ 18 F]FDG PET in Staging Grade 1–2, Estrogen Receptor Positive Breast Cancer.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 11, p. 1954, doi. 10.3390/diagnostics11111954
- By:
- Publication type:
- Article
Circulating tumour DNA as biomarker for rectal cancer: A systematic review and meta-analyses.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1083285
- By:
- Publication type:
- Article
Distress in patients with cancer – on the need to distinguish between adaptive and maladaptive emotional responses.
- Published in:
- Acta Oncologica, 2017, v. 56, n. 7, p. 1026, doi. 10.1080/0284186X.2017.1280848
- By:
- Publication type:
- Article
Possible molecular mechanisms involved in the toxicity of angiogenesis inhibition.
- Published in:
- 2007
- By:
- Publication type:
- research
Novel drugs that target the metabolic reprogramming in renal cell cancer.
- Published in:
- Cancer & Metabolism, 2016, v. 4, p. 1, doi. 10.1186/s40170-016-0154-8
- By:
- Publication type:
- Article
Development of bioluminescent chick chorioallantoic membrane (CAM) models for primary pancreatic cancer cells: a platform for drug testing.
- Published in:
- Scientific Reports, 2017, p. 44686, doi. 10.1038/srep44686
- By:
- Publication type:
- Article
Rscreenorm: normalization of CRISPR and siRNA screen data for more reproducible hit selection.
- Published in:
- BMC Bioinformatics, 2018, v. 19, n. 1, p. 1, doi. 10.1186/s12859-018-2306-z
- By:
- Publication type:
- Article
Conversion of a colorectal cancer guideline into clinical decision trees with assessment of validity.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Advancing wide implementation of precision oncology: A liquid nitrogen‐free snap freezer preserves molecular profiles of biological samples.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 9, p. 10979, doi. 10.1002/cam4.5781
- By:
- Publication type:
- Article
The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments.
- Published in:
- Frontiers in Immunology, 2017, p. 1, doi. 10.3389/fimmu.2017.00631
- By:
- Publication type:
- Article
In Vivo Efficacy of Umbilical Cord Blood Stem Cell-Derived NK Cells in the Treatment of Metastatic Colorectal Cancer.
- Published in:
- Frontiers in Immunology, 2017, v. 8, p. 1, doi. 10.3389/fimmu.2017.00087
- By:
- Publication type:
- Article
Severe toxicity of capecitabine following uncomplicated treatment with 5-fluorouracil/leucovorin.
- Published in:
- 2011
- By:
- Publication type:
- journal article